Phospho-HGS (Y334) Antibody

What is HGS and what is the significance of its phosphorylation at Y334?

HGS (Hepatocyte growth factor-regulated tyrosine kinase substrate) is a critical protein that regulates endosomal sorting and plays an essential role in the recycling and degradation of membrane receptors. It functions by sorting monoubiquitinated membrane proteins into the multivesicular body, which targets these proteins for lysosome-dependent degradation .

Phosphorylation at Tyrosine 334 (Y334) is a key post-translational modification of HGS that occurs in response to several growth factors and cytokines, including Epidermal Growth Factor (EGF), Interleukin-2 (IL-2), Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), and Hepatocyte Growth Factor (HGF) . This phosphorylation event is thought to regulate the protein's activity in intracellular signal transduction pathways.

When associated with STAM (Signal Transducing Adapter Molecule), phosphorylated HGS suppresses DNA signaling upon stimulation by IL-2 and GM-CSF, and may function as a direct effector of PI3-kinase in the vesicular pathway via early endosomes . The Phospho-HGS (Y334) antibody specifically detects the phosphorylated form of HGS at this critical regulatory site.

What are the optimal applications and experimental conditions for using Phospho-HGS (Y334) Antibody?

Phospho-HGS (Y334) Antibody has been validated for multiple research applications, with specific recommended dilutions:

The antibody is specifically designed to detect endogenous levels of HGS protein only when phosphorylated at Y334 . For optimal results, experimental conditions should be determined and optimized by each investigator based on their specific research setup and sample types.

It's important to note that this antibody is strictly for research use only and is not intended for use in human or clinical diagnosis .

What is the molecular basis for HGS Y334 phosphorylation and its role in signaling pathways?

HGS Y334 phosphorylation represents a critical node in several signaling cascades. The phosphorylation event occurs in response to stimulation with growth factors and cytokines including EGF, IL-2, GM-CSF, and HGF . This suggests that HGS phosphorylation is part of receptor tyrosine kinase and cytokine receptor signaling pathways.

Mechanistically, phosphorylation at Y334 appears to modulate HGS function in several ways:

• When phosphorylated and associated with STAM, HGS suppresses DNA signaling in response to IL-2 and GM-CSF stimulation

• Phosphorylated HGS may function as a direct effector of PI3-kinase in the vesicular pathway

• It may regulate trafficking between early and late endosomes through recruitment of clathrin

• Phosphorylation may affect HGS's ability to concentrate ubiquitinated receptors within clathrin-coated regions

Understanding this molecular basis is essential for interpreting experimental results when using the Phospho-HGS (Y334) Antibody in signaling studies.

How should Phospho-HGS (Y334) Antibody be stored and handled to maintain its specificity?

For optimal antibody performance and longevity, follow these storage and handling recommendations:

The antibody is typically supplied at a concentration of 1 mg/mL in phosphate-buffered saline (PBS) containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide as preservative .

For storage:

• Store at -20°C for up to 1 year from the date of receipt for long-term preservation

• Avoid repeated freeze-thaw cycles, which can degrade antibody quality and reduce binding specificity

• For short-term use (within 1-2 weeks), the antibody can be stored at 4°C

When handling:

• Centrifuge the antibody briefly before opening the tube

• Work with small aliquots to minimize freeze-thaw cycles

• Use appropriate laboratory safety precautions, as the formulation contains sodium azide

• Allow frozen antibody to thaw completely at room temperature before use

Proper storage and handling are critical for maintaining the phospho-specificity of the antibody and ensuring consistent experimental results .

What are the best validation strategies to confirm the phospho-specificity of Phospho-HGS (Y334) Antibody?

Validating phospho-specificity is crucial for generating reliable results. Implement these strategies:

• Phosphatase Treatment Control:

  • Treat half of your sample with lambda phosphatase

  • Compare antibody recognition between treated and untreated samples

  • Signal should disappear in phosphatase-treated samples

• Stimulation/Inhibition Experiments:

  • Stimulate cells with known activators (EGF, IL-2, GM-CSF, or HGF)

  • In parallel, pretreat some samples with relevant kinase inhibitors

  • Confirm increased signal with stimulation and decreased signal with inhibition

• Peptide Competition Assay:

  • Pre-incubate antibody with phosphorylated and non-phosphorylated peptides

  • The phospho-peptide should block signal while non-phospho-peptide should not

• Phosphomimetic and Phospho-Dead Mutants:

  • Express Y334E (phosphomimetic) and Y334F (phospho-dead) HGS mutants

  • Verify differential recognition by the antibody

• Mass Spectrometry Correlation:

  • Correlate antibody detection with MS-based identification of phosphorylation at Y334

These validation approaches are similar to those used in developing high-affinity phospho-specific antibodies in recent research .

How can I optimize Western blot protocols specifically for Phospho-HGS (Y334) detection?

For detecting phosphorylated HGS at Y334 by Western blot, consider these optimization steps:

• Sample Preparation:

  • Use phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride, and β-glycerophosphate) in lysis buffers

  • Process samples quickly and keep them cold to prevent dephosphorylation

  • Consider using SDS-free lysis buffers for certain applications

• Gel and Transfer Parameters:

  • Use 8-10% gels for optimal resolution of HGS (approximately 86 kDa)

  • Perform wet transfer at 4°C to maintain phospho-epitopes

  • Consider adding SDS (0.1%) to transfer buffer to improve transfer of large proteins

• Blocking and Antibody Incubation:

  • Use 5% BSA in TBST for blocking (not milk, which contains phosphatases)

  • Dilute primary antibody in 5% BSA/TBST at 1:500-1:2000 based on signal strength

  • Incubate overnight at 4°C for optimal binding

• Detection Optimization:

  • Use high-sensitivity ECL reagents for detection of low abundance phosphorylation

  • Consider fluorescent secondary antibodies for better quantification

  • Include total HGS detection on separate blots or after stripping

• Controls and Normalization:

  • Include positive controls (EGF, IL-2, GM-CSF, or HGF stimulated samples)

  • Run a total HGS blot in parallel for normalization

  • Include a housekeeping protein control (β-actin, GAPDH)

This methodological approach has been effective in detecting phosphorylated proteins with similar properties .

What upstream regulators induce HGS Y334 phosphorylation and how can this be experimentally manipulated?

Understanding the regulators of Y334 phosphorylation allows for experimental manipulation of HGS function:

Known Upstream Regulators:

Experimental Manipulation Strategies:

• Receptor Activation:

  • Treat cells with the stimuli listed above at indicated concentrations

  • Use time-course experiments to determine optimal phosphorylation timing

• Kinase Inhibitors:

  • Pretreat cells with PI3K inhibitors (LY294002, Wortmannin)

  • Investigate Src family kinase inhibitors (PP2, Dasatinib)

  • Test EGFR inhibitors for EGF-mediated phosphorylation

• Genetic Approaches:

  • Express constitutively active forms of upstream kinases

  • Use siRNA or CRISPR to knockout candidate kinases

  • Introduce phospho-resistant (Y334F) mutant HGS

• Physiological Context:

  • Examine HGS Y334 phosphorylation during receptor internalization

  • Study endosomal sorting under different stimulation conditions

  • Investigate the role during stress responses

These experimental manipulations can help determine the functional significance of Y334 phosphorylation in different cellular contexts .

How can Phospho-HGS (Y334) Antibody be integrated into phospho-flow cytometry protocols?

Phospho-flow cytometry allows for single-cell analysis of phosphorylation events. Integrating Phospho-HGS (Y334) Antibody requires these specialized considerations:

• Cell Fixation and Permeabilization:

  • Use paraformaldehyde (2-4%) for fixation (10-15 minutes)

  • For permeabilization, methanol (-20°C) works well for most phospho-epitopes

  • Alternatively, try saponin-based or commercial permeabilization buffers

• Antibody Titration:

  • Perform careful titration of Phospho-HGS (Y334) Antibody (starting at 1:50-1:200)

  • Use positive control samples (stimulated with EGF or other known activators)

  • Confirm specificity with phosphatase-treated negative controls

• Staining Protocol:

  • Block with 2% FBS or specialized blocking buffer for 30 minutes

  • Include isotype control at equivalent concentration

  • Extend incubation time (2 hours room temperature or overnight at 4°C)

  • Use fluorophore-conjugated secondary antibody specific to rabbit IgG

• Multiparameter Analysis:

  • Combine with surface markers (added before fixation)

  • Consider intracellular markers for cell type identification

  • Include additional phospho-antibodies for pathway analysis

• Data Analysis Considerations:

  • Use median fluorescence intensity (MFI) for quantification

  • Calculate phosphorylation index relative to unstimulated controls

  • Consider phosphorylation in subpopulations defined by other markers

This approach follows principles similar to those used in T cell receptor signaling analysis with phospho-specific antibodies .

What are the technical challenges when using Phospho-HGS (Y334) Antibody in co-immunoprecipitation?

Co-immunoprecipitation (Co-IP) with phospho-specific antibodies presents unique challenges:

• Maintaining Phosphorylation Status:

  • Use strong phosphatase inhibitor cocktails (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

  • Keep samples cold throughout the procedure

  • Consider crosslinking approaches to preserve transient interactions

• Antibody Binding Optimization:

  • Determine optimal antibody-to-bead ratio (typically 2-5 μg antibody per 50 μL beads)

  • Test different binding conditions (overnight at 4°C vs. 4 hours)

  • Consider covalent coupling to beads for cleaner results

• Lysis Buffer Considerations:

  • Use mild non-ionic detergents (NP-40, Triton X-100) at 0.5-1%

  • Include protease inhibitors alongside phosphatase inhibitors

  • Optimize salt concentration (150-300 mM NaCl) to balance specificity and yield

• Washing Strategy:

  • Implement progressive washing with decreasing stringency

  • Typically 4-5 washes with lysis buffer followed by TBS washes

  • Monitor phosphorylation status after washing steps

• Elution and Detection:

  • Consider native elution with competing phosphopeptide

  • For denaturing elution, use SDS loading buffer at 70°C (not 95°C) to minimize antibody contamination

  • Probe blots for interacting partners and confirm specificity with control IPs

These technical considerations help preserve the phospho-dependent interactions while minimizing background and non-specific binding.

How does detection of phosphorylated HGS compare with other phospho-tyrosine PTM detection strategies?

Detecting phosphorylated HGS represents one example of tyrosine phosphorylation analysis that can be compared with other detection strategies:

Comparative Analysis of Phospho-Tyrosine Detection Methods:

Methodological Considerations:

• Antibody-Based Detection:

  • Phospho-HGS (Y334) Antibody provides site-specific detection similar to other engineered phospho-antibodies

  • The development of such antibodies often requires phage display technology and careful validation

  • Compared to pan-phosphotyrosine antibodies, the Phospho-HGS (Y334) Antibody offers greater specificity but narrower detection scope

• Mass Spectrometry Approaches:

  • MS offers unbiased detection of multiple phosphorylation sites simultaneously

  • Can detect novel sites not covered by available antibodies

  • Requires specialized equipment and expertise compared to antibody methods

• Stability Considerations:

  • Phosphotyrosine is generally more stable than phosphohistidine, which has a labile phosphoramidate (P-N) bond

  • This influences sample preparation methods and storage conditions

• Mimetic Approaches:

  • Some research utilizes phosphomimetic compounds (like pTza for phosphohistidine)

  • No widely used stable mimetic for phosphotyrosine exists, as the phosphoester bond is relatively stable

Understanding these comparative methodologies helps researchers select the most appropriate approach for their specific experimental questions when studying HGS phosphorylation or other tyrosine phosphorylation events.